基本信息
views: 14
Career Trajectory
Bio
I am a researcher with strong vocation in Organic Chemistry, having spent more than 18 years hardly working in labs. Since 2001, I participated as researcher in the synthesis of new fragrances from 2003 to 2005, being still student. During my Ph. D. degree I was immersed in different projects: Total Synthesis of Bioactive compounds and analogues, and developing new asymmetric synthetic methodologies in Organic Chemistry. I was working in different approaches to synthesize natural products as Stevastelins, Pironetin and macrolides type-antibiotics as Streptovaricin U. These efforts were recognized with 5 international publications in a short period of 3 years. Additionally, during the same period I was the first author in a review. Moreover, I was the main part in the development, synthesis and applications of unprecedented bicyclic sulfur chiral ylides derived from α-aminoacids: proline, S-methylcisteine and methionine. As result of this work, I signed a breakthrough article in Chem.Commun. in 2009 and this work supposed my main tail in my Ph. D. degree defense. As consequence of further works in the same project, I published 3 more articles. In this period (4 years) I also participated in teaching duties in UMA and at distance Education National University (UNED), what finished with the three different accreditations to be Professor in University by ANECA (National Agency for Quality Evaluation and Accreditation, Spain) in 2010. After my Ph. D. degree I joined as Head of Technical department in a company dedicated to prevent and control Legionella in water for human consumption. Then, I moved to Dortmund (Germany) in September of 2011, to join in the group of Prof. Herbert Waldmann and Dr. Kamal Kumar in the Max Planck Institute of Molecular Physiology, as postdoctoral researcher. I worked in the development of new strategies in Diversity Oriented Synthesis. The success of this research was demonstrated with a publication of an important article as first author in Nature Communications (2015). In a parallel way, I was working in a new synthetic methodology that afforded a facile dipolar entry to diverse dihydro-1 H-1,2,4-triazoles. In 2016 I collected the fruits of the hard work done during 2014-2015. Thus, I published up 3 excellent articles in top international journals. An important review about Scaffold Diversity Synthesis and its applications in probe and drug discovery, which was published in Angew. Chem. Int. Ed. Just in five years has been cited more than 80 times. In Germany, I also teached and monitored too many students. Since September 2014 to January 2016, I was a researcher in the European Lead Factory (ELF), working along with TAROS Chemicals as a partner in the validation of new synthetic strategies to develop new drugs. After a mandatory leave due to conciliation of family life because of the born of my daughter, I moved to Spain where I finished a Master thesis to get Secondary school title to enable as a teacher. Since 2019 I work as a scientist in University of Málaga, where I divide my time in researching and teaching duties. Recently, I was awarded with the Spin-Off Award from UMA with a project called GARLAB, getting own space in the Green Ray building. In 2021 I got funding to develop my own research line in University of Malaga. In 2022 I was named expert scientist assistant by Malta Medicines Authority. Nowadays I am professor and researcher in UMA and UNED (Spain).
Research Interests
Papers共 36 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
MARINE DRUGSno. 12 (2023): 637
Exploration of Drug Sciencepp.180-209, (2023)
ChemInformno. 35 (2016)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn